Data through FY2026 Q3 (Jun 30, 2026)
Verve Therapeutics, Inc.
Company profile for Verve Therapeutics, Inc. covers 12 filings across the reporting window. FY2025 certified median offer: $133,703.
- FY2025 certified median
- $133,703
- Total filings
- 12
- FY2025 25th–75th percentile
- $115,669–$140,795
- Top job title
- Senior Manager, Analytical CMC
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 6 | $122,000 | $107,000 | $140,000 |
| FY2025 | 6 | $133,703 | $115,669 | $140,795 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Senior Manager, Analytical CMC2 filings
- Associate Scientist, RNA Technology & Engineering1 filings
- Manager, Next Generation Sequencing1 filings
- Research Associate, Next Generation Sequencing1 filings
- Scientist, Editor Development1 filings
- Scientist II, Analytics1 filings
- Scientist II, Computational Biology1 filings
- Scientist II, Editing Discovery1 filings
- Scientist, Next Generation Sequencing1 filings
- Senior Research Associate, Preclinical Pharmacology1 filings
Top cities
- Boston11 filings
- Somerville1 filings